The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
5.39
+0.27 (5.27%)
At close: Jun 26, 2026, 4:00 PM EDT
5.30
-0.09 (-1.67%)
After-hours: Jun 26, 2026, 7:44 PM EDT
The Oncology Institute Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for The Oncology Institute stock have an average target of 7.25, with a low estimate of 5.00 and a high estimate of 8.00. The average target predicts an increase of 34.51% from the current stock price of 5.39.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for The Oncology Institute stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | +48.42% | Jun 8, 2026 |
| Noble Financial | Noble Financial | Buy Reiterates $8 | Buy | Reiterates | $8 | +48.42% | May 8, 2026 |
| Needham | Needham | Buy Reiterates $5 | Buy | Reiterates | $5 | -7.24% | May 8, 2026 |
Unknown Analyst B. Riley Securities No rating | B. Riley Securities | Buy Reiterates $6 → $8 | Buy | Reiterates | $6 → $8 | +48.42% | Mar 13, 2026 |
Financial Forecast
Revenue This Year
659.28M
from 502.73M
Increased by 31.14%
Revenue Next Year
820.98M
from 659.28M
Increased by 24.53%
EPS This Year
n/a
EPS Next Year
n/a
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 675.9M | 870.2M | |
| Avg | 659.3M | 821.0M | |
| Low | 643.6M | 777.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 34.4% | 32.0% | |
| Avg | 31.1% | 24.5% | |
| Low | 28.0% | 17.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.